A virtual screening approach applied to the search for trypanothione reductase inhibitors

Journal of Medicinal Chemistry

Volumn 40, Issue 15, 1997, Pages 2412-2423

  Horvath, Dragos ^a  

^a CEREP   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPROTOZOAL AGENT; OXIDOREDUCTASE INHIBITOR; TRYPANOTHIONE;

ALGORITHM; ARTICLE; BINDING AFFINITY; DRUG SCREENING; ENZYME BINDING; LIGAND BINDING; MATHEMATICAL ANALYSIS;

ALGORITHMS; DATABASES, FACTUAL; ENZYME INHIBITORS; MODELS, CHEMICAL; MOLECULAR CONFORMATION; NADH, NADPH OXIDOREDUCTASES; THERMODYNAMICS;

EID: 0030815956     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm9603781     Document Type: Article

References (75)

1. De Castro, S. L. The challenge of Chagas' disease chemotherapy: an update of drugs assayed against Trypanosoma Cruzi. Acta Trop. 1993, 53, 83-98.
2. Etah, E. A. O; Smith, K.; Fairlamb, A. H. Trypanothione detoxication systems in trypanosomatids, Spring Meeting of the British Society for Parasitology, London, 1993.
3. Cotgreave, I. A.; Moldeus, P.; Orrenius, S. Host biochemical defense mechanisms against oxidants. Annu. Rev. Pharmacol. Toxicol. 1988, 28, 189-212.
4. Janes, W.; Schulz, G. E. Role of the charged groups of glutathione reductase in the catalysis of glutathione reductase: crystallographic and kinetic studies with synthetic analogues. Biochemistry 1990, 29, 4022-4030.
5. Jockers-Scheruebl, M. C.; Schirmer, R. H.; Krauth-Siegel, R. L. Trypanothione Reductase from Trypanosoma Cruzi, catalytic properties of the enzyme and inhibition studies with trypanocidal compounds. Eur. J. Biochem. 1989, 180, 267-272.
6. Pai, E. F.; Schulz, G. E. The catalytic mechanism of glutathione reductase as derived from X-ray diffraction analyses of reaction intermediates. J. Biol. Chem. 1983, 258, 1752-1757.
7. Karplus, P. A.; Schulz, G. E. Refined structure of glutathione reductase at 1.54 Å resolution. J. Mol. Biol. 1987, 195, 701-729.
8. Karplus, P. A.; Schulz, G. E. Substrate binding and catalysis by glutathione reductase as derived from refined enzyme-substrate crystal structures at 2 Å resolution. J. Mol. Biol. 1989, 210, 163-180.
9. Kuriyan, J.; Kong, X.-P.; Krishna, T. S. R.; Sweet, R. M.; Murgolo, N. J.; Field, H.; Cerami, A.; Henderson, G. B. X-ray structure of trypanothione reductase from Crithidia fasciculata at 2.4 Å resolution. Proc. Natl. Acad. Sci. U.SA. 1991, 88, 8764-8768.
10. Hunter, W. N.; Bailey, S.; Habash, J.; Harrop, S. J.; Helliwell, J. R.; Aboagye-Kwarteng, T.; Smith, K.; Fairlamb, A. H. Active site of trypanothione reductase, a target for rational drug design J. Mol. Biol. 1992, 227, 322-333.
11. 1-glutathionylspermidine disulfide at 0.28 nm resolution. Eur. J. Biochem. 1993, 213, 67-75.
12. Benson, T. J.; McKie, J. H.; Garforth, J.; Borges, A.; Fairlamb, A. H.; Douglas, K.T. Rationally designed selective inhibitors of trypanothione reductase; phenothiazines and related tricyclics as lead structures. Biochem. J. 1992, 286, 9-11.
13. Bruns, R. F.; Simmons, R. M. A.; Howbert, J. J.; Waters, D. C.; Threlkeld, P. C.; Gitter, B. D. Virtual screening as a tool for evaluating chemical libraries lecture at Exploiting Molecular Diversity - Small Molecule Libraries For Drug Discovery, Jan. 23-25, 1995, La Jolla, CA.
14. Smelie, A. S.; Crippen, G. M.; Richards, W. G. Fast drug-receptor mapping by site-directed distances. A novel method of predicting new pharmacological leads. J. Chem. Inf. Comput. Sci. 1991, 31, 386-392.
15. Martin, Y. C. 3D database searching in drug design. J. Med. Chem. 1992, 35, 2145-2154.
16. Eisen, M. B.; Wiley, D. C.; Karplus, M.; Hubbard, R. E. HOOK: a program for finding new molecular architectures that satisfy the chemical and steric requirements of a macromolecule binding site. Proteins 1994, 19, 199-221.
17. Bohacek, R. S.; McMartin, C. Multiple highly diverse structures complementary to enzyme binding sites: results of extensive application of a de novo design method incorporating combinatorial growth. J. Am. Chem. Soc. 1994, 116, 5560-5571.
18. Boehm, H. J. The computer program LUDI: a new simple method for the de novo ligand design. J. Comput.-Aided Mol. Des. 1992, 6, 61-78.
19. Gillet, V.; Johnson, A. P.; Mata, P.; Sike, S.; Williams, P. SPROUT: A program for structure generation. J. Comput. Aided Mol. Des. 1993, 7, 123-157.
20. Oprea, T. I.; Waller, C. L.; Marshall, G. R. Three-dimensional quantitative structure-activity relationship of human immunodeficiency virus(I) protease inhibitors. 2. Predictive power using limited exploration of alternate binding modes. J. Med. Chem. 1994, 37, 2206-2215.
21. Sternberg, M. J.; King, R. D.; Lewis, R. A.; Muggelton, S. Application of machine learning to structural molecular biology. Philos. Trans. R. Soc. London B: Biol. Sci. 1994, 344, 365-371.
22. Benigni, R.; Cotta-Ramusion, M.; Giorgi, F.; Gallo, C. Molecular similarity matrices and quantitative structure-activity relationships: a case study with methodological implications. J. Med. Chem. 1995, 38, 629-635.
23. Hocart, S. J.; Reddy, W.; Murphy, W. A.; Coy, D. H. Three-dimensional quantitative structure-activity relationships of somatostatin analogues. 1. Comparative molecular field analysis of growth hormone release-inhibiting potencies. J. Med. Chem. 1995, 38, 1974-1989.
24. Diudea, M. V.; Ivanciuc, O. Molecular Topology (in Romanian), Comprex Editions; Cluj-Napoca: Romania, 1995.
25. Ortiz, A. R.; Pisabarro, M. T.; Gago, F.; Wade, R. C. Prediction of drug binding affinities by comparative binding energy analysis. J. Med. Chem. 1995, 38, 2681-2691.
26. Hansch, C. Drug design; Ariens, E. J., Ed.; Academic Press: New York, 1971; Vol. 16, p 271.
27. van Gunsteren, W. F. Methods for calculation of free energies and binding constants. Successes and problems. In Computer Simulations of Biomolecular Systems; van Gunsteren, W. F., Wiener, S. ESCOM: Leiden, 1989; pp 27-59.
28. Struthers, R. S.; Rivier, J.; Hagler, A. T. Design of peptide analogs: Theoretical simulation of conformation, energetics and dynamics. In Conformationally Directed Drug Design; Peptides and Nucleic Acids as Templates or Targets; Vida, J. A., Gordon, M., Eds.; American Chemical Society: Washington, DC, 1984; pp 239-261.
29. McQuarie, D. A. Statistical Mechanics; Harper Collins Publishers: New York, 1976.
30. Mezei, M.; Beveridge, D. Free energy simulations Ann. N.Y. Acad. Sci. 1986, 482, 1-23.
31. Mezei, M. The finite difference thermodynamic integration, tested on calculating the hydration free energy difference between acetone and dimethylamine in water. J. Chem. Phys, 1987, 86, 7084-7088.
32. Hodel, A.; Rice, L. M.; Simonson, T.; Fox, R. O.; Brunger, A. T. Proline cis-trans isomerization in staphylococcal nuclease: multisubstrate free energy perturbation calculations. Protein Sci. 1995, 4, 636-654.
33. Stouten, P. F. W.; Froemmel, C.; Nakamura, H.; Sander, C. An effective solvation term based on atomic occupancies for use in protein simulations. Mol. Simul. 1993, 10, 97-120.
34. Luty, B. A.; Zacharias, M.; Wasserman, Z. R.; Stouten, P. F. W.; Hodge, C. N.; McCammon, J. A. A molecular mechanics/grid method for evaluation of ligand-receptor interactions J. Comput. Chem. 1995, 16, 454-464.
35. Baillet, S.; Buisine, E.; Horvath, D.; Maes, L.; Bonnet, B.; Sergheraert, C. 2-Aminodiphenylsulphides as inhibitors of trypanothione reductase. Bioorg. Med. Chem. 1996, 4, 891-899.
36. Vajda, S.; Weng, Z.; Rosenfeld, R.; DeLisi, C. Effect of Conformational Flexibility and Solvation on Receptor-Ligand Binding Free Energies. Biochemistry 1994, 33, 13977-13988.
37. Moutiez, M.; Lucas, V.; Davioud, E.; Tartar, A.; Sergheraert, C. Indolylmaleimide derivatives: synthesis and biological activities as new potential Trypanothione Reductase inhibitors; The IVth congress of COST-ACRIVAL antiparasitic chemotherapy; Grenada, Spain, June 5-6, 1995.
38. Moutiez, M. Ph.D. Thesis, University of Lille II, France, 1995.
39. Krauth-Siegel, R. L.; Lohrer, H.; Buecheler, U. S.; Schirmer, R. H. In Biochemical Protozoology; Coombe, G. H., North, M. J., Eds.; Taylor and Francis: London, 1991.
40. Gomez, R. F.; Moutiez, M.; Aumercier, M.; Bethegnies, G.; Luyckx, M.; Ouaissi, A.; Tartar, A.; Sergheraert, C. 2-Aminodiphenylsulphides as new inhibitors of trypanothione reductase. Int. J. Antimicrob. Agents 1995, 6, 111-118.
41. Ponasik, J. A.; Strickland, C.; Faerman, C.; Savvides, S.; Karplus, P. A.; Ganem, B.; Kukoamine A and other hydrophobic acylpolyamines: potent and selective inhibitors of Crithidia fasciculata trypanothione reductase. Biochem. J. 1995, 311, 371-375.
42. Girault, S.; Baillet, S.; Lucas, V.; Davioud, E.; Tartar, A.; Sergheraert, C. Bis - Aminodiphenylsulphides as potent inhibitors of the TR from T. Cruzi; poster at the 5th European COST Conference on Antiparasitic Chemotherapy; Heidelberg, May 23-24, 1996.
43. Moreno, S. N. J.; Carnieri, E. G. S.; Docampo, R. Inhibition of Trypanosoma cruzy trypanothione reductase by crystal violet. Mol. Biochem. Parasitol. 1994, 67, 313-320.
44. Howard, A. E.; Kollman, P. A. An analysis of current methodologies for conformational search of complex molecules. J. Med. Chem. 1988, 31, 1669-1675.
45. Leach, A. R. An algorithm to identify a molecule's most different conformations. J. Chem. Inf. Comput. Sci. 1994, 34, 661-670.
46. Leach, A. R.; Prout, K.; Dolata, D. P. The application of artificial intelligence to the conformational analysis of strained molecules. J. Comput. Chem. 1990, 11, 680-693.
47. Discover 2.9.0/3.1.0 User Guide, Jan. 1993, BIOSYM Technologies (Molecular Simulations Inc.), San Diego, CA.
48. Smellie, A.; Teig, S. L.; Towbin, P. Poling: promoting conformational variation. J. Comput. Chem. 1995, 16, 171-187.
49. Ermer, O. Calculation of molecular properties using force fields. Applications in organic chemistry. Struct. Bonding 1976, 27, 161-211.
50. Hagler, A. T.; Lifson, S.; Dauber, P. Consistent force field studies of intermolecular forces in hydrogen bonded crystals. II. A benchmark for the objective comparison of alternative force fields. J. Am. Chem. Soc. 1979, 101, 5122-5130.
51. Press, W. H.; Flannery, B. P.; Teukolsky, S. A.; Vetterling, W. T. Numerical Recipes: The Art of Scientific Computing; Cambridge University Press: Cambridge, 1986.
52. Albert, A.; Serjeant, E. P. Ionization Constants of Acids & Bases: Butler & Tanner: London, 1962.
53. Protein Data Bank; Chemistry Department, Brookhaven National Laboratory, Upton NY 11973.
54. Gilson, M. K.; Honig, B. The inclusion of electrostatic hydration energies in molecular mechanics calculations. J. Comput.-Aided Mol. Des. 1991, 5, 5-20.
55. Still, W. C.; Tempczyk, A.; Hawley, R. C.; Hendrickson, T. Semianalytical treatment of solvation for molecular mechanics and dynamics. J. Am. Chem. Soc. 1990, 112, 6127-6129.
56. Eisenberg, D.; McLahan, A. D. Solvation energy in protein folding and binding. Nature 1986, 319, 199-203.
57. Mehler, E. L.; Eichele, G. Electrostatic effects in water-accessible regions of proteins. Biochemistry 1984, 23, 3887-3891.
58. Jackson, J. D. Classical Electrodynamics; J. Wiley & Sons: New York, 1975.
59. Horvath, D.; van Belle, D.; Lippens, G. Development and parametrization of continuum solvent models. II. An unified approach to the solvation problem. J. Chem.Phys. 1996, 105, 4197-4210.
60. Brooks, C. L. III; Karplus, M.; Montgomery-Pettitt, B. Proteins: A theoretical Perspective of Dynamics, Structure and Thermodynamics; Advances in Chemical Physics vol. LXXI; John Wiley & Sons: New York, 1988.
61. Brooks, C. L. III. Thermodynamics of ionic solvation: Monte Carlo simulation of aqueous chloride and bromide ions. J. Phys. Chem. 1986, 90, 6680-6684.
62. ACD, Available Chemicals Directory, Copyright 1995, MDL Information Systems Inc., San Leandro, CA.
63. Aumercier, M.; Meziane-Cherif, D.; Moutiez, M.; Tartar, A.; Sergheraert, C. A microplate assay to screen trypanothione reductase inhibitors. Anal. Biochem. 1994, 223, 161-164.
64. Horvath, D.; van Belle, D.; Lippens, G.; Wodak, S. J. Development and parametrization of continuum solvent models. I. Models based on the boundary element method. J. Chem. Phys. 1996, 104, 6679-6695.
65. Searle, M. S.; Williams, D. H.; Gerhard, U. Partitioning of Free Energy Contributions in the Estimation of Binding Constants: Residual Motions and Consequences for Amide-Amine Hydrogen Bond Strengths. J. Am. Chem. Soc. 1992, 114, 10697-10704.
66. Stewart, J. J. P. MOPAC: a semiempirical molecular orbital program. J. Comput.-Aided Mol. Des. 1990, 4, 1-105.
67. Head, R. D.; Smythe, M. L.; Oprea, T. I.; Waller, C. L.; Green, S. M.; Marshall, G. R. VALIDATE: A New Method for the Receptor-Based Prediction of Binding Affinities of Novel Ligands. J. Am. Chem. Soc. 1996, 118, 3959-3969.
68. Boehm, H. J. The development of a simple empirical scoring function to estimate the binding constant for a protein-ligand complex of known three-dimensional structure. J. Comput.-Aided Mol. Des. 1994, 8, 243-256.
69. Pickett, S. E.; Sternberg, M. E. Empirical scale of conformational entropy in protein folding. J. Mol. Biol. 1993, 231, 2674-2684.
70. Zoellner, H. Handbook of Enzyme Inhibitors, Part A; VCH Verlag GmbH: Weinheim, 1993.
71. Jacoby, E. M.; Schlichting, I.; Lantwin, C. B.; Kabsch, W.; Krauth-Siegel, R. L. Crystal structure of the Trypanoaoma Cruzi trypanothione reductase-mepacrine complex. Proteins 1996, 24, 73-80.
72. Katchalski-Katzir, E.; Shariv, I.; Eisenstein, M.; Friesem, A. A.; Ailalo, C.; Vakser, I. A. Molecular surface recognition: determination of geometric fit between proteins and their ligands by correlation techniques. Proc. Natl. Acad. Sci. U.S.A. 1992, 89, 2195-2199.
73. Harrison, R. W.; Kourinov, I. V.; Andrews, L. C. The Fourier-Green's function and the rapid evaluation of molecular potentials. Protein Eng. 1994, 7, 359-369.
74. So, S. S.; Karplus, M. Evolutionary optimization in quantitative structure-activity relationship: an application of neural networks. J. Med. Chem. 1996, 39, 1521-1530.
75. Cavin, J. C.; Krassner, S. M.; Rodriguez, E. Plant-derived alkaloids active against Trypanosoma Cruzi. J. Ethnopharmacol. 1987, 19, 89.